NCT00006377View on ClinicalTrials.gov

Doxorubicin, Paclitaxel, and Carboplatin in Treating Patients With Primary Stage III, Stage IV, or Recurrent Endometrial Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

June 30, 2000

Primary Completion Date

January 31, 2003

Study Completion Date

January 31, 2003

Conditions
Endometrial Cancer
Interventions
DRUG

carboplatin

DRUG

doxorubicin hydrochloride

DRUG

paclitaxel

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00006377 - Doxorubicin, Paclitaxel, and Carboplatin in Treating Patients With Primary Stage III, Stage IV, or Recurrent Endometrial Cancer | Biotech Hunter | Biotech Hunter